MIRA INFORM REPORT

 

 

Report Date :

08.01.2011

 

IDENTIFICATION DETAILS

 

Name :

ESPEE BIOPHARMA & FINECHEM LLC

 

 

Registered Office :

1220 N. Market Street Suite 806 - Wilmington - New Castle - DE

 

 

Country :

United States 

 

 

Date of Incorporation :

21.04.2009

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Pharmaceutical ingredients and healthcare products manufacturer and supplier

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Small Company 

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30, 2010

 

Country Name

Previous Rating

                   (01.04.2010)                  

Current Rating

(30.06.2010)

United States 

a1

a1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

GEOPOLITICS - UNITED STATES

 

POLITICAL DATA

ECONOMIC DATA

Form of Government: Federal


Economic Risk: Nil

Currency: USD

Branch Situation:Stable

 

 

IDENTIFICATION

 

Ordered as:

Espee Biopharma & Finechem LLC

Address in the order:

500 Lake Cook Road, Suite 350, Deerfield, IL 60015

 

 

Legal Name:

Espee Biopharma & Finechem LLC

 

 

Legal Address

1220 N. Market Street Suite 806 - Wilmington - New Castle - DE - USA (incorporators)

Operative Address

500 Lake Cook Rd, Suite 350 - Deerfield, IL 60015 - USA (headquarters)

Telephone:

(888) 851-6667 / (201) 253-9053

ID :

4679062

Fax:

(888) 317-5667

Legal Form:

Limited Liability Company

Email:

info@espeeusa.com

Registered in:

Delaware

Website:

http://www.espeeusa.com/

Date Created:

1985

Manager:

Mr. Ravi Patel, President

Date Incorporated:

April, 21st. 2009

Staff:

20

Stock:

NA

 

 

Value:

NA

Activity:

Pharmaceutical ingredients and healthcare products manufacturer and supplier

 

 

BUSINESS

 

HISTORY

 

The company was created in 1985

PRINCIPAL ACTIVITY

 

Pharmaceutical ingredients and healthcare products manufacturer and supplier

Products/Services description:

 

Their business range includes APIs, non APIs, pharmaceutical intermediates, dyes and dye intermediates, fine chemicals and raw materials, psyllium products, health care products and contract manufacturing.

 

Their active pharmaceutical ingredients include ranitidine, and sucralose.

 

They also offer services such as custom manufacturing, warehouse-distribution, regulatory compliance and new product development.

 

The company was incorporated in Delaware due to taxs purposes. However, it is headquartered in Illinois.

 

Sales are:

 

Wholesale

Clients:

 

Professionals of the industry

Suppliers:

 

- USFDA

- WHO - GMP

- ISO Standards

 

(Among others)

Operations area:

 

National, International

The subject employs 20 employee(s)

LOCATION

Headquarters

 

The legal address of the company is that of the registran officer: 1220 N. MARKET STREET SUITE 806 - WILMINGTON - NEW CASTLE - DE - USA

 

However, it is headquartered at: 500 Lake Cook Rd,

Suite 350 - Deerfield, IL 60015 - US

 

Shareholders - Manager - Related Companies

 

Listed at the stock exchange:

 

NO

Shareholders Parent Company(ies):

 

This is a private company.

Management:

 

Ravi Patel, President

Related Companies:

 

Espee Wellness

Espee Dyes & Chemicals

Espee Drugs

 

 

Financials - COMMERCIAL TRENDS AND FORECAST

 

As a private company the subject does not publish any financial statements.

We have contacted Mr. Ravi Patel, who refused to provide us any financial data without knowing the name of the inquiring party.

Legal Fillings

 There are no UCC** files listed with the Secretary of State of Illinois.

 

There are no legal filings listed with the District Court.

 

THE COMPANY IS NOT LISTED ON THE OFAC LIST.*

 

For information:

 

* The Specially Designated Nationals (SDN) List is a publication of OFAC which lists individuals and organizations with whom United States citizens and permanent residents are prohibited from doing business.

 

** The Uniform Commercial Code (UCC) is one of a number of uniform acts that have been promulgated in conjunction with efforts to harmonize the law of sales and other commercial transactions in all 50 states within the United States of America. 

 

The UCC deals primarily with transactions involving personal property (movable property), not real property (immovable property).

 

It allows a creditor to notify other creditors about a debtor’s assets used as collateral for a secured transaction by filing a public notice (financing statement) with a particular filing office.

 

The Uniform Commercial Code Bureau files and maintains on financial obligations (including IRS liens) incurred by individuals (in business as a sole proprietor), business entities and corporations.

 

 

Rating

Local credit bureau gave a Correct credit rate.

 

The company is in Good Standing. This means that all local and federal taxes were paid on due date.

 Final Opinion

 

This is a small sized American company which employs 20 people and has 25 years of experience in the market.

 

We don't have any financial information on the company, nor do we have any payments experience.

 

We suggest working with guarantees.

 

 

SUMMARY

 


FINANCIAL SUMMARY


DEBT COLLECTIONS AND PAYMENTS

Profitability

N.A.

Public Records

NO

Indebtedness

N.A.

Payments

N.A.

Cash

N.A.

 

 

 


APPENDIX

 

Person Interviewed

 

Mr. Ravi Patel

Position

 

President

Comments

 

The person contacted refused to provide us any information on grounds of confidentiality.

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.37

UK Pound

1

Rs.70.38

Euro

1

Rs.58.93

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.